Novonesis
Danish biotechnology company
From Wikipedia, the free encyclopedia
Novonesis (the trading name of Novozymes A/S)[1] is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
| Novonesis | |
| Type | Publicly traded Aktieselskab |
| Nasdaq Nordic: NSIS-B | |
| ISIN | DK0060336014 |
| Industry | Biotechnology |
| Predecessor | |
| Founded | January 29, 2024 |
| Headquarters | Lyngby, Denmark |
| Products | Enzymes, microbiological cultures, biopharmaceutical ingredients, human milk oligosaccharides |
| Revenue |
|
| |
| |
| Parent | Novo Holdings A/S |
| Website | novonesis |
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.[2]
The merger, first announced in December 2022, was the largest merger in history between two Danish companies.[3][4] It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.[5]
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.[6]
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries.[7]
History
The intended merger was first announced on December 12, 2022[8][9], cleared by the European Commission on December 12, 2023[10], and Novonesis was founded on January 29, 2024.[11][12]
The name "Novonesis" was coined in connection with the merger. Company materials describe it as a constructed name combining "novo" (Latin for "new") and "genesis" ("origin" or "beginning" in Greek).[12][13]
Novozymes was known for producing industrial enzymes used in products such as detergents[14], biofuels, and food.[15] Chr. Hansen specialized in bacterial cultures and probiotics used in dairy products, dietary supplements and for agricultural applications.[16]
In 2025, Novonesis reached an agreement with DSM-Firmenich to acquire its shares of the Feed Enzyme Alliance.[17]